These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 12890852)

  • 21. The molecular background to hypophosphataemic rickets.
    Rowe PS
    Arch Dis Child; 2000 Sep; 83(3):192-4. PubMed ID: 10952628
    [No Abstract]   [Full Text] [Related]  

  • 22. Hypophosphataemia due to FGF-23 producing B cell non-Hodgkin's lymphoma.
    Elderman JH; Wabbijn M; de Jongh F
    BMJ Case Rep; 2016 Apr; 2016():. PubMed ID: 27118742
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical utility of systemic venous sampling of FGF23 for identifying tumours responsible for tumour-induced osteomalacia.
    Ito N; Shimizu Y; Suzuki H; Saito T; Okamoto T; Hori M; Akahane M; Fukumoto S; Fujita T
    J Intern Med; 2010 Oct; 268(4):390-4. PubMed ID: 20698924
    [No Abstract]   [Full Text] [Related]  

  • 24. Oncogenic osteomalacia in a patient with a fibrocystic nodule of the breast.
    Gascón A; Cobeta-Garcia JC; Iglesias E; Lázaro JM; Muniesa JA
    Nephrol Dial Transplant; 1999 Jun; 14(6):1561-3. PubMed ID: 10383027
    [No Abstract]   [Full Text] [Related]  

  • 25. [FGF-23].
    Miyauchi A
    Nihon Rinsho; 2004 Feb; 62 Suppl 2():378-84. PubMed ID: 15035156
    [No Abstract]   [Full Text] [Related]  

  • 26. [X-linked hypophosphatemic rickets].
    Tanaka H
    Nihon Rinsho; 2006 Jun; Suppl 2():120-5. PubMed ID: 16817365
    [No Abstract]   [Full Text] [Related]  

  • 27. The PEX gene: its role in X-linked rickets, osteomalacia, and bone mineral metabolism.
    Rowe PS
    Exp Nephrol; 1997; 5(5):355-63. PubMed ID: 9386970
    [No Abstract]   [Full Text] [Related]  

  • 28. FGF23 is processed by proprotein convertases but not by PHEX.
    Benet-Pagès A; Lorenz-Depiereux B; Zischka H; White KE; Econs MJ; Strom TM
    Bone; 2004 Aug; 35(2):455-62. PubMed ID: 15268897
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tumor-induced osteomalacia associated with a maxillofacial tumor producing fibroblast growth factor 23: report of a case and review of the literature.
    Mori Y; Ogasawara T; Motoi T; Shimizu Y; Chikazu D; Tamura K; Fukumoto S; Takato T
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Mar; 109(3):e57-63. PubMed ID: 20219587
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Osteomalacia by a mesenchymal-FGF23-producing tumour: Successful treatment with radiofrequency ablation. A case report.
    Igney-Oertel A; Artunc F; Henes J; Hoffmann R; Clasen S
    Joint Bone Spine; 2016 Oct; 83(5):603-4. PubMed ID: 27006265
    [No Abstract]   [Full Text] [Related]  

  • 31. Tumour-induced osteomalacia.
    Minisola S; Peacock M; Fukumoto S; Cipriani C; Pepe J; Tella SH; Collins MT
    Nat Rev Dis Primers; 2017 Jul; 3():17044. PubMed ID: 28703220
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased circulatory level of biologically active full-length FGF-23 in patients with hypophosphatemic rickets/osteomalacia.
    Yamazaki Y; Okazaki R; Shibata M; Hasegawa Y; Satoh K; Tajima T; Takeuchi Y; Fujita T; Nakahara K; Yamashita T; Fukumoto S
    J Clin Endocrinol Metab; 2002 Nov; 87(11):4957-60. PubMed ID: 12414858
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment and outcomes of tumor-induced osteomalacia associated with phosphaturic mesenchymal tumors: retrospective review of 12 patients.
    Zuo QY; Wang H; Li W; Niu XH; Huang YH; Chen J; You YH; Liu BY; Cui AM; Deng W
    BMC Musculoskelet Disord; 2017 Sep; 18(1):403. PubMed ID: 28934935
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A rare case of multiple phosphaturic mesenchymal tumors along a tendon sheath inducing osteomalacia.
    Arai R; Onodera T; Terkawi MA; Mitsuhashi T; Kondo E; Iwasaki N
    BMC Musculoskelet Disord; 2017 Feb; 18(1):79. PubMed ID: 28193220
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Fibroblast growth factor 23 (FGF 23): a new fosfaturic hormone?].
    Negri AL
    Nefrologia; 2003; 23(6):478-81. PubMed ID: 15002780
    [No Abstract]   [Full Text] [Related]  

  • 36. Aberrant Phex function in osteoblasts and osteocytes alone underlies murine X-linked hypophosphatemia.
    Yuan B; Takaiwa M; Clemens TL; Feng JQ; Kumar R; Rowe PS; Xie Y; Drezner MK
    J Clin Invest; 2008 Feb; 118(2):722-34. PubMed ID: 18172553
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Octreotide Is Ineffective in Treating Tumor-Induced Osteomalacia: Results of a Short-Term Therapy.
    Ovejero D; El-Maouche D; Brillante BA; Khosravi A; Gafni RI; Collins MT
    J Bone Miner Res; 2017 Aug; 32(8):1667-1671. PubMed ID: 28459498
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of fifteen novel PHEX gene mutations in Finnish patients with hypophosphatemic rickets.
    Tyynismaa H; Kaitila I; Näntö-Salonen K; Ala-Houhala M; Alitalo T
    Hum Mutat; 2000 Apr; 15(4):383-4. PubMed ID: 10737991
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Tumor-induced rickets/osteomalacia].
    Fukumoto S
    Nihon Rinsho; 2005 Oct; 63 Suppl 10():523-8. PubMed ID: 16279694
    [No Abstract]   [Full Text] [Related]  

  • 40. Case records of the Massachusetts General Hospital. Case 33-2011. A 56-year-old man with hypophosphatemia.
    Bergwitz C; Collins MT; Kamath RS; Rosenberg AE
    N Engl J Med; 2011 Oct; 365(17):1625-35. PubMed ID: 22029985
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.